Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Glioma Clinical Trial Leadership

Patrick Wen

MD

🏢Dana-Farber Cancer Institute🌐USA

Director of Center for Neuro-Oncology

125
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Patrick Wen leads glioma drug development at Dana-Farber and internationally, including pivotal trials of vorasidenib for IDH-mutant glioma and response criteria (RANO) development. His work has shaped modern endpoints and trial design in neuro-oncology. He chairs numerous cooperative group neuro-oncology committees and platform trials.

Share:

🧪Research Fields 研究领域

IDH inhibitors vorasidenib
glioma drug development
RANO response criteria
GBM platform trials
neuro-oncology leadership

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Patrick Wen 的研究动态

Follow Patrick Wen's research updates

留下邮箱,当我们发布与 Patrick Wen(Dana-Farber Cancer Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment